Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

15.19
Delayed Data
As of Feb 24
 +0.38 / +2.57%
Today’s Change
10.50
Today|||52-Week Range
21.75
-17.54%
Year-to-Date
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close14.81
Today’s open14.66
Day’s range14.66 - 15.29
Volume394,668
Average volume (3 months)382,828
Market cap$699.1M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+76.00%
Earnings growth (this year)+680.56%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+19.51%
P/E ratio33.0
Price/Sales2.54
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA-0.74-3.56%
MGNXMacroGenics Inc+0.14+0.72%
PGNXProgenics Pharmaceut...+0.12+1.17%
ACIUAC Immune Ltd-0.47-3.81%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$251.5M
Annual profit (last year)-$2.8M
Net profit margin-1.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, COO &
Chief Scientist
Zi Ping Luo
CEO, Class III Director &
Chief Science Officer
Yong Feng Zhang
Corporate headquarters
Rancho Cucamonga, California

Forecasts


Search for Jobs